Sign In
Buy XRAY
$13.37
-0.370 (-2.69%)
At Close: Jul 31, 2026
Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives
08:30am, Monday, 08'th Sep 2025
Determined that Wellspect will Deliver Greater Financial and Strategic Benefits to Stockholders as Part of the Company Determined that Wellspect will Deliver Greater Financial and Strategic Benefits t
Dentsply Sirona to Participate in Upcoming Investor Conferences
04:30pm, Tuesday, 26'th Aug 2025
CHARLOTTE, N.C., Aug. 26, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.
Is the Options Market Predicting a Spike in DENTSPLY Stock?
10:45am, Thursday, 21'st Aug 2025
Investors need to pay close attention to XRAY stock based on the movements in the options market lately.
Dentsply Sirona: Turnaround Potential And Digital Workflows
09:11am, Tuesday, 19'th Aug 2025
XRAY's EDS and Wellspect are the key to stabilizing their results going forward. OIS and CTS continue to decline, but SureSmile grows in Europe. Their new CEO will also prioritize execution, rather th
International Markets and Dentsply (XRAY): A Deep Dive for Investors
10:15am, Monday, 11'th Aug 2025
Explore Dentsply's (XRAY) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Why Dentsply International (XRAY) is a Top Growth Stock for the Long-Term
10:46am, Friday, 08'th Aug 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
DENTSPLY SIRONA Inc. (XRAY) Q2 2025 Earnings Call Transcript
09:15am, Friday, 08'th Aug 2025
DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Q2 2025 Earnings Call August 7, 2025 8:30 AM ET Company Participants Andrea Daley - Vice President of Investor Relations Daniel T. Scavilla - President, CEO & Direc
XRAY Stock Rises on Q2 Earnings & Revenues Beat, Adjusted Margins Up
12:11pm, Thursday, 07'th Aug 2025
DENTSPLY SIRONA tops Q2 earnings estimates with margin gains, but revenue declines and U.S. weakness persists.
Dentsply (XRAY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
10:32am, Thursday, 07'th Aug 2025
The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimate
Dentsply International (XRAY) Tops Q2 Earnings and Revenue Estimates
08:16am, Thursday, 07'th Aug 2025
Dentsply International (XRAY) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.49 per share a year ago.
Dentsply Sirona Reports Second Quarter 2025 Results
06:00am, Thursday, 07'th Aug 2025
CHARLOTTE, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the second quarter of 2025.
XRAY or MMSI: Which Is the Better Value Stock Right Now?
12:41pm, Monday, 04'th Aug 2025
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or Merit Medical (MMSI). But which of these two stocks presents investo
Should Value Investors Buy Dentsply Sirona (XRAY) Stock?
10:41am, Monday, 04'th Aug 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?
09:36am, Monday, 04'th Aug 2025
XRAY's Imaging strength and SureSmile growth might have lifted Q2 performance, but Byte's drag and macro pressures likely clouded the top-line momentum.
Dentsply International (XRAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Thursday, 31'st Jul 2025
Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
